These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 38967704

  • 1. Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia.
    Luzzi S, Bektaşoğlu PK, Doğruel Y, Güngor A.
    Neurosurg Rev; 2024 Jul 05; 47(1):305. PubMed ID: 38967704
    [Abstract] [Full Text] [Related]

  • 2. Letter to the editor: "Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia".
    Kaamini E, Santhoshkumar M.
    Neurosurg Rev; 2024 Aug 14; 47(1):430. PubMed ID: 39141183
    [Abstract] [Full Text] [Related]

  • 3. Letter to editor: Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia.
    Rizvi SVZ, Zaidi SMF.
    Neurosurg Rev; 2024 Aug 01; 47(1):383. PubMed ID: 39085665
    [Abstract] [Full Text] [Related]

  • 4. Letter to the editor: "Beyond nimodipine: Advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia".
    Chen G, Xu K.
    Neurosurg Rev; 2024 Jul 26; 47(1):361. PubMed ID: 39060440
    [No Abstract] [Full Text] [Related]

  • 5. SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.
    Macdonald RL, Jaja B, Cusimano MD, Etminan N, Hanggi D, Hasan D, Ilodigwe D, Lantigua H, Le Roux P, Lo B, Louffat-Olivares A, Mayer S, Molyneux A, Quinn A, Schweizer TA, Schenk T, Spears J, Todd M, Torner J, Vergouwen MD, Wong GK, Singh J, SAHIT Collaboration.
    Transl Stroke Res; 2013 Jun 26; 4(3):286-96. PubMed ID: 24323299
    [Abstract] [Full Text] [Related]

  • 6. Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials.
    Dayyani M, Sadeghirad B, Grotta JC, Zabihyan S, Ahmadvand S, Wang Y, Guyatt GH, Amin-Hanjani S.
    Stroke; 2022 Jun 26; 53(6):1993-2005. PubMed ID: 35354302
    [Abstract] [Full Text] [Related]

  • 7. An Update on the Efficacy and Safety Profile of Clazosentan in Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Song J, Xue YQ, Wang YJ, Xu P, Sun DK, Chen W.
    World Neurosurg; 2019 Mar 26; 123():e235-e244. PubMed ID: 30496924
    [Abstract] [Full Text] [Related]

  • 8. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
    Shen J, Pan JW, Fan ZX, Xiong XX, Zhan RY.
    J Neurosurg; 2013 Jul 26; 119(1):180-9. PubMed ID: 23641823
    [Abstract] [Full Text] [Related]

  • 9. Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.
    Mayer SA, Aldrich EF, Bruder N, Hmissi A, Macdonald RL, Viarasilpa T, Marr A, Roux S, Higashida RT.
    Stroke; 2019 Oct 26; 50(10):2738-2744. PubMed ID: 31394993
    [Abstract] [Full Text] [Related]

  • 10. An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage.
    Maruhashi T, Higashi Y.
    Expert Opin Pharmacother; 2021 Aug 26; 22(12):1601-1614. PubMed ID: 33823726
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of intrathecal nicardipine on cerebral vasospasm in non-traumatic subarachnoid hemorrhage: a systematic review.
    Stuart D, Christian R, Uschmann H, Palokas M.
    JBI Database System Rev Implement Rep; 2018 Oct 26; 16(10):2013-2026. PubMed ID: 30335041
    [Abstract] [Full Text] [Related]

  • 12. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
    Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T.
    Cerebrovasc Dis; 2017 Oct 26; 44(1-2):59-67. PubMed ID: 28463833
    [Abstract] [Full Text] [Related]

  • 13. The effectiveness and safety of clazosentan in treating aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.
    Al-Salihi MM, Saha R, Abd Elazim A, Helal A, Sabah Al-Jebur M, Al-Salihi Y, Ayyad A.
    J Clin Neurosci; 2024 Aug 26; 126():173-181. PubMed ID: 38924824
    [Abstract] [Full Text] [Related]

  • 14. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C, Zhao S, Zang Y, Zhao W, Song Q, Feng S, Hu L, Gu F.
    Neurol Res; 2018 Apr 26; 40(4):283-291. PubMed ID: 29540123
    [Abstract] [Full Text] [Related]

  • 15. Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study.
    Pearl JD, Macdonald RL.
    Acta Neurochir Suppl; 2008 Apr 26; 105():207-10. PubMed ID: 19066110
    [Abstract] [Full Text] [Related]

  • 16. Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2).
    Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N.
    Acta Neurochir Suppl; 2013 Apr 26; 115():27-31. PubMed ID: 22890639
    [Abstract] [Full Text] [Related]

  • 17. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, Heindel W, Ringelstein EB, Stummer W, Pluta RM, Hesselmann V.
    J Neurosurg; 2016 Jan 26; 124(1):51-8. PubMed ID: 26162034
    [Abstract] [Full Text] [Related]

  • 18. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.
    Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A, CONSCIOUS-1 Investigators.
    Stroke; 2008 Nov 26; 39(11):3015-21. PubMed ID: 18688013
    [Abstract] [Full Text] [Related]

  • 19. Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.
    Wang X, Li YM, Li WQ, Huang CG, Lu YC, Hou LJ.
    PLoS One; 2012 Nov 26; 7(10):e47778. PubMed ID: 23082215
    [Abstract] [Full Text] [Related]

  • 20. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm.
    Ehtisham A, Taylor S, Bayless L, Samuels OB, Klein MW, Janzen JM.
    South Med J; 2009 Feb 26; 102(2):150-3. PubMed ID: 19139684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.